$NHC
NATIONAL HEALTHCARE CORP

2017 Q2 Form 10-Q Financial Statement

#000143774917013682 Filed on August 03, 2017

View on sec.gov

Income Statement

Concept 2017 Q2 2016 Q2
Revenue $238.7M $227.8M
YoY Change 4.8% 1.27%
Cost Of Revenue $142.7M $135.1M
YoY Change 5.63% 2.43%
Gross Profit $96.00M $92.70M
YoY Change 3.56% -0.32%
Gross Profit Margin 40.22% 40.7%
Selling, General & Admin $10.10M $10.30M
YoY Change -1.94% 3.0%
% of Gross Profit 10.52% 11.11%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $10.50M $9.400M
YoY Change 11.7% 1.08%
% of Gross Profit 10.94% 10.14%
Operating Expenses $82.70M $77.10M
YoY Change 7.26% 0.52%
Operating Profit $12.14M $14.64M
YoY Change -17.1% -6.78%
Interest Expense $1.219M $939.0K
YoY Change 29.82% 57.02%
% of Operating Profit 10.04% 6.41%
Other Income/Expense, Net $5.189M $4.925M
YoY Change 5.36% 19.25%
Pretax Income $17.33M $19.57M
YoY Change -11.44% -1.36%
Income Tax $6.758M $7.700M
% Of Pretax Income 39.0% 39.35%
Net Earnings $10.66M $11.87M
YoY Change -10.21% -3.98%
Net Earnings / Revenue 4.46% 5.21%
Basic Earnings Per Share $0.70 $0.78
Diluted Earnings Per Share $0.70 $0.78
COMMON SHARES
Basic Shares Outstanding 15.19M 15.27M
Diluted Shares Outstanding 15.22M 15.29M

Balance Sheet

Concept 2017 Q2 2016 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $209.0M $179.3M
YoY Change 16.56% -5.33%
Cash & Equivalents $60.85M $37.54M
Short-Term Investments $148.1M $141.8M
Other Short-Term Assets $29.10M $30.70M
YoY Change -5.21% 3.72%
Inventory $7.198M $7.137M
Prepaid Expenses
Receivables $79.64M $77.23M
Other Receivables $3.800M $2.900M
Total Short-Term Assets $328.7M $297.3M
YoY Change 10.58% -3.51%
LONG-TERM ASSETS
Property, Plant & Equipment $555.5M $553.3M
YoY Change 0.4% 6.49%
Goodwill $17.60M $17.60M
YoY Change 0.0%
Intangibles
YoY Change
Long-Term Investments $36.30M $36.00M
YoY Change 0.83% 2.56%
Other Assets $216.0M $237.0M
YoY Change -8.85% 31.57%
Total Long-Term Assets $771.5M $790.3M
YoY Change -2.38% 3.24%
TOTAL ASSETS
Total Short-Term Assets $328.7M $297.3M
Total Long-Term Assets $771.5M $790.3M
Total Assets $1.100B $1.088B
YoY Change 1.17% 1.3%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $14.70M $21.80M
YoY Change -32.57% 27.49%
Accrued Expenses $78.90M $77.60M
YoY Change 1.68% 2.65%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $3.600M $3.400M
YoY Change 5.88% 6.25%
Total Short-Term Liabilities $137.0M $140.8M
YoY Change -2.68% -17.64%
LONG-TERM LIABILITIES
Long-Term Debt $120.0M $120.0M
YoY Change 0.0% 186.4%
Other Long-Term Liabilities $17.35M $17.37M
YoY Change -0.1% -85.31%
Total Long-Term Liabilities $137.4M $137.4M
YoY Change -0.01% -14.2%
TOTAL LIABILITIES
Total Short-Term Liabilities $137.0M $140.8M
Total Long-Term Liabilities $137.4M $137.4M
Total Liabilities $410.8M $278.2M
YoY Change 47.66% -15.95%
SHAREHOLDERS EQUITY
Retained Earnings $401.2M $380.6M
YoY Change 5.41%
Common Stock $152.0K $153.0K
YoY Change -0.65%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $688.7M $671.5M
YoY Change
Total Liabilities & Shareholders Equity $1.100B $1.088B
YoY Change 1.17% 1.3%

Cashflow Statement

Concept 2017 Q2 2016 Q2
OPERATING ACTIVITIES
Net Income $10.66M $11.87M
YoY Change -10.21% -3.98%
Depreciation, Depletion And Amortization $10.50M $9.400M
YoY Change 11.7% 1.08%
Cash From Operating Activities $27.30M $22.10M
YoY Change 23.53% 39.87%
INVESTING ACTIVITIES
Capital Expenditures -$8.600M -$22.70M
YoY Change -62.11% 118.27%
Acquisitions
YoY Change
Other Investing Activities -$8.800M -$2.600M
YoY Change 238.46% -48.0%
Cash From Investing Activities -$17.50M -$25.30M
YoY Change -30.83% 64.29%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -7.000M -6.300M
YoY Change 11.11% -10.0%
NET CHANGE
Cash From Operating Activities 27.30M 22.10M
Cash From Investing Activities -17.50M -25.30M
Cash From Financing Activities -7.000M -6.300M
Net Change In Cash 2.800M -9.500M
YoY Change -129.47% 43.94%
FREE CASH FLOW
Cash From Operating Activities $27.30M $22.10M
Capital Expenditures -$8.600M -$22.70M
Free Cash Flow $35.90M $44.80M
YoY Change -19.87% 70.99%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2016 nhc Annual Excess Coverage
AnnualExcessCoverage
9000000
nhc Annual Excess Coverage
AnnualExcessCoverage
9000000
CY2017Q2 nhc Common Stock Increase Shares Authorized
CommonStockIncreaseSharesAuthorized
15000000
nhc Direct Business Coverage Statutory Limits
DirectBusinessCoverageStatutoryLimits
1000000
CY2017Q2 nhc Dividends And Other Net Realized Gains And Losses On Sales Of Securities
DividendsAndOtherNetRealizedGainsAndLossesOnSalesOfSecurities
1899000
CY2016Q2 nhc Dividends And Other Net Realized Gains And Losses On Sales Of Securities
DividendsAndOtherNetRealizedGainsAndLossesOnSalesOfSecurities
1901000
nhc Dividends And Other Net Realized Gains And Losses On Sales Of Securities
DividendsAndOtherNetRealizedGainsAndLossesOnSalesOfSecurities
3623000
nhc Dividends And Other Net Realized Gains And Losses On Sales Of Securities
DividendsAndOtherNetRealizedGainsAndLossesOnSalesOfSecurities
3762000
CY2017Q2 nhc Income Tax Rate Reconciliation Exercise Of Stock Options Amount
IncomeTaxRateReconciliationExerciseOfStockOptionsAmount
123000
CY2016Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
65912000
nhc Income Tax Rate Reconciliation Exercise Of Stock Options Amount
IncomeTaxRateReconciliationExerciseOfStockOptionsAmount
244000
nhc Increase Decrease In Due To Third Party Payors
IncreaseDecreaseInDueToThirdPartyPayors
931000
nhc Increase Decrease In Due To Third Party Payors
IncreaseDecreaseInDueToThirdPartyPayors
1756000
nhc Noncontrolling Interest Increase From Capital Contribution
NoncontrollingInterestIncreaseFromCapitalContribution
970000
CY2017Q2 nhc Number Of Assisted Living Facilities
NumberOfAssistedLivingFacilities
25
CY2017Q2 nhc Number Of Beds
NumberOfBeds
9597
CY2017Q2 nhc Number Of Homecare Programs
NumberOfHomecarePrograms
36
CY2017Q2 nhc Number Of Independent Living Facilities
NumberOfIndependentLivingFacilities
5
CY2017Q2 nhc Number Of Skilled Nursing Centers
NumberOfSkilledNursingCenters
76
nhc Proceeds Payments Tax Benefit Expense From Stockbased Compensation
ProceedsPaymentsTaxBenefitExpenseFromStockbasedCompensation
nhc Proceeds Payments Tax Benefit Expense From Stockbased Compensation
ProceedsPaymentsTaxBenefitExpenseFromStockbasedCompensation
-1134000
CY2017Q2 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
17950000
CY2016Q4 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
17019000
CY2017Q2 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
14738000
CY2016Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
18593000
CY2017Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
79640000
CY2016Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
82531000
CY2017Q2 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
53311000
CY2016Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
211457000
us-gaap Adjustment To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net
AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet
-1134000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
494000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
832000
CY2017Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
740000
CY2016Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
208000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
832000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
494000
CY2017Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
7408000
CY2016Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
5743000
CY2017Q2 us-gaap Assets
Assets
1100246000
CY2016Q4 us-gaap Assets
Assets
1087447000
CY2017Q2 us-gaap Assets Current
AssetsCurrent
328731000
CY2017Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
394224000
CY2016Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
373516000
CY2017Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
73540000
CY2016Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
66068000
CY2017Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
213785000
CY2016Q4 us-gaap Assets Current
AssetsCurrent
290857000
CY2017Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
164225000
CY2016Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
185968000
CY2017Q2 us-gaap Available For Sale Securities
AvailableForSaleSecurities
312091000
CY2016Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
321717000
CY2017Q2 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
119086000
CY2016Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
108730000
CY2017Q2 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
1396000
CY2016Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
3157000
CY2017Q2 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
194401000
CY2016Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
216144000
CY2017Q2 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost
81923000
CY2016Q4 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost
91211000
CY2017Q2 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
81424000
CY2016Q4 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
89269000
CY2017Q2 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
66519000
CY2016Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
79827000
CY2017Q2 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
66747000
CY2016Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
79502000
CY2017Q2 us-gaap Available For Sale Securities Debt Maturities After Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost
1155000
CY2016Q4 us-gaap Available For Sale Securities Debt Maturities After Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost
749000
CY2017Q2 us-gaap Available For Sale Securities Debt Maturities After Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue
1155000
CY2016Q4 us-gaap Available For Sale Securities Debt Maturities After Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue
717000
CY2017Q2 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
14628000
CY2016Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
14181000
CY2017Q2 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
14628000
CY2016Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
14216000
CY2017Q2 us-gaap Available For Sale Securities Debt Maturities Without Single Maturity Date Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue
163954000
CY2016Q4 us-gaap Available For Sale Securities Debt Maturities Without Single Maturity Date Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue
183704000
CY2017Q2 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
3587000
CY2016Q4 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
3481000
CY2017Q2 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
24927000
CY2016Q4 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
26748000
CY2017Q2 us-gaap Capital Leases Future Minimum Payments Due
CapitalLeasesFutureMinimumPaymentsDue
34667000
CY2017Q2 us-gaap Capital Leases Future Minimum Payments Due Current
CapitalLeasesFutureMinimumPaymentsDueCurrent
5200000
CY2017Q2 us-gaap Capital Leases Future Minimum Payments Due In Five Years
CapitalLeasesFutureMinimumPaymentsDueInFiveYears
5200000
CY2017Q2 us-gaap Capital Leases Future Minimum Payments Due In Four Years
CapitalLeasesFutureMinimumPaymentsDueInFourYears
5200000
CY2017Q2 us-gaap Capital Leases Future Minimum Payments Due In Three Years
CapitalLeasesFutureMinimumPaymentsDueInThreeYears
5200000
CY2017Q2 us-gaap Capital Leases Future Minimum Payments Due In Two Years
CapitalLeasesFutureMinimumPaymentsDueInTwoYears
5200000
CY2017Q2 us-gaap Capital Leases Future Minimum Payments Due Thereafter
CapitalLeasesFutureMinimumPaymentsDueThereafter
8667000
CY2017Q2 us-gaap Capital Leases Future Minimum Payments Interest Included In Payments
CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments
6153000
CY2017Q2 us-gaap Capital Leases Future Minimum Payments Present Value Of Net Minimum Payments
CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments
28514000
CY2017Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
60848000
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
26335000
CY2016Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
37543000
CY2016Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
31589000
CY2015Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
49314000
CY2017Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
66596000
CY2016Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
54243000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
35007000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
4929000
CY2017Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.48
CY2016Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.45
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.93
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.85
CY2017Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2017Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2017Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
45000000
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
30000000
CY2017Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
30000000
CY2017Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
45000000
CY2017Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
15195030
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
15162938
CY2017Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
15195030
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
15162938
CY2017Q2 us-gaap Common Stock Value
CommonStockValue
152000
CY2016Q4 us-gaap Common Stock Value
CommonStockValue
152000
CY2017Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
18694000
CY2016Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
22841000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
30855000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
44098000
us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
5635000
CY2017Q2 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-86000
CY2016Q2 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-181000
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
CY2017Q2 us-gaap Continuing Care Retirement Communities Advance Fees Obligation For Future Services Amount
ContinuingCareRetirementCommunitiesAdvanceFeesObligationForFutureServicesAmount
3236000
CY2016Q4 us-gaap Continuing Care Retirement Communities Advance Fees Obligation For Future Services Amount
ContinuingCareRetirementCommunitiesAdvanceFeesObligationForFutureServicesAmount
3236000
CY2017Q2 us-gaap Costs And Expenses
CostsAndExpenses
227319000
CY2016Q2 us-gaap Costs And Expenses
CostsAndExpenses
213127000
us-gaap Costs And Expenses
CostsAndExpenses
450698000
us-gaap Costs And Expenses
CostsAndExpenses
425091000
CY2017Q2 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
4886000
CY2016Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
3362000
CY2017Q2 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
25178000
CY2016Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
22072000
CY2017Q2 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
5639000
CY2016Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
5244000
CY2017Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
10481000
CY2016Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
9495000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
20776000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
18849000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
20776000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
18849000
us-gaap Dividends Common Stock
DividendsCommonStock
12981000
us-gaap Dividends Common Stock
DividendsCommonStock
14125000
CY2017Q2 us-gaap Dividends Payable Current
DividendsPayableCurrent
7294000
CY2016Q4 us-gaap Dividends Payable Current
DividendsPayableCurrent
6818000
CY2017Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.70
us-gaap Gain Loss On Sale Of Securities Net
GainLossOnSaleOfSecuritiesNet
238000
CY2017Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.39
CY2016Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.394
us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
4337000
CY2016Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.78
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.54
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.69
CY2017Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.70
CY2016Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.78
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.54
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.68
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.389
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.391
CY2017Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
7951000
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P5Y
us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
37959000
us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
41963000
us-gaap Health Care Organization Revenue
HealthCareOrganizationRevenue
478700000
us-gaap Health Care Organization Revenue
HealthCareOrganizationRevenue
457356000
CY2017Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
17327000
CY2016Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
19566000
us-gaap Gain Loss On Sale Of Securities Net
GainLossOnSaleOfSecuritiesNet
540000
CY2017Q2 us-gaap Goodwill
Goodwill
17600000
CY2016Q4 us-gaap Goodwill
Goodwill
17600000
CY2017Q2 us-gaap Health Care Organization Other Revenue
HealthCareOrganizationOtherRevenue
11610000
CY2016Q2 us-gaap Health Care Organization Other Revenue
HealthCareOrganizationOtherRevenue
11281000
us-gaap Health Care Organization Other Revenue
HealthCareOrganizationOtherRevenue
22894000
us-gaap Health Care Organization Other Revenue
HealthCareOrganizationOtherRevenue
22763000
CY2017Q2 us-gaap Health Care Organization Patient Service Revenue
HealthCareOrganizationPatientServiceRevenue
227847000
CY2016Q2 us-gaap Health Care Organization Patient Service Revenue
HealthCareOrganizationPatientServiceRevenue
216487000
us-gaap Health Care Organization Patient Service Revenue
HealthCareOrganizationPatientServiceRevenue
455806000
us-gaap Health Care Organization Patient Service Revenue
HealthCareOrganizationPatientServiceRevenue
434593000
CY2017Q2 us-gaap Health Care Organization Revenue
HealthCareOrganizationRevenue
239457000
CY2016Q2 us-gaap Health Care Organization Revenue
HealthCareOrganizationRevenue
227768000
CY2017Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1854000
CY2016Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1615000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
3380000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
3120000
CY2017Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6758000
CY2016Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7700000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
14757000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
16398000
CY2017Q2 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
84000
CY2016Q2 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
143000
us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
133400
us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
229000
CY2017Q2 us-gaap Income Tax Reconciliation Tax Contingencies
IncomeTaxReconciliationTaxContingencies
146200
CY2016Q2 us-gaap Income Tax Reconciliation Tax Contingencies
IncomeTaxReconciliationTaxContingencies
190000
us-gaap Income Tax Reconciliation Tax Contingencies
IncomeTaxReconciliationTaxContingencies
321000
us-gaap Income Tax Reconciliation Tax Contingencies
IncomeTaxReconciliationTaxContingencies
365000
CY2017Q2 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
2447000
CY2016Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
4665000
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-3855000
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
1675000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
904000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-3072000
us-gaap Increase Decrease In Accrued Salaries
IncreaseDecreaseInAccruedSalaries
-12601000
us-gaap Increase Decrease In Accrued Salaries
IncreaseDecreaseInAccruedSalaries
-15333000
us-gaap Increase Decrease In Customer Deposits
IncreaseDecreaseInCustomerDeposits
-757000
us-gaap Increase Decrease In Customer Deposits
IncreaseDecreaseInCustomerDeposits
-34000
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
1540000
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
244000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
1048000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
1073000
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
969000
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
967000
CY2017Q2 us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
CY2016Q2 us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
97137
CY2017Q2 us-gaap Interest Expense
InterestExpense
1219000
CY2016Q2 us-gaap Interest Expense
InterestExpense
939000
us-gaap Interest Expense
InterestExpense
2277000
us-gaap Interest Expense
InterestExpense
1893000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
1524000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
1390000
us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
-418000
us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
216000
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-2218000
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-2288000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-310000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-431000
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
4819000
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
609000
CY2017Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
1436000
CY2016Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
1409000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
2954000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
2816000
CY2017Q2 us-gaap Inventory Net
InventoryNet
7198000
CY2016Q4 us-gaap Inventory Net
InventoryNet
7508000
CY2017Q2 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
36345000
CY2016Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
37242000
CY2017Q2 us-gaap Labor And Related Expense
LaborAndRelatedExpense
142684000
CY2016Q2 us-gaap Labor And Related Expense
LaborAndRelatedExpense
135068000
us-gaap Labor And Related Expense
LaborAndRelatedExpense
280739000
us-gaap Labor And Related Expense
LaborAndRelatedExpense
265088000
CY2017Q2 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
10079000
CY2016Q2 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
10319000
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
20167000
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
20646000
CY2017Q2 us-gaap Liabilities
Liabilities
410788000
CY2016Q4 us-gaap Liabilities
Liabilities
417836000
CY2017Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1100246000
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1087447000
CY2017Q2 us-gaap Liabilities Current
LiabilitiesCurrent
137048000
CY2016Q4 us-gaap Liabilities Current
LiabilitiesCurrent
150928000
CY2017Q2 us-gaap Long Term Debt
LongTermDebt
120000000
CY2016Q4 us-gaap Long Term Debt
LongTermDebt
120000000
CY2017Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
120000000
CY2016Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
120000000
CY2017Q2 us-gaap Malpractice Loss Contingency Number Of Claims
MalpracticeLossContingencyNumberOfClaims
61
CY2017Q2 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
148137000
CY2016Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
138013000
CY2017Q2 us-gaap Marketable Securities Restricted Current
MarketableSecuritiesRestrictedCurrent
21963000
CY2016Q4 us-gaap Marketable Securities Restricted Current
MarketableSecuritiesRestrictedCurrent
22773000
CY2017Q2 us-gaap Marketable Securities Restricted Noncurrent
MarketableSecuritiesRestrictedNoncurrent
141991000
CY2016Q4 us-gaap Marketable Securities Restricted Noncurrent
MarketableSecuritiesRestrictedNoncurrent
160931000
CY2017Q2 us-gaap Minority Interest
MinorityInterest
789000
CY2016Q4 us-gaap Minority Interest
MinorityInterest
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-14073000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-4597000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
8775000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-36902000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
40305000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
46428000
CY2017Q2 us-gaap Net Income Loss
NetIncomeLoss
10655000
CY2016Q2 us-gaap Net Income Loss
NetIncomeLoss
11866000
us-gaap Net Income Loss
NetIncomeLoss
23383000
us-gaap Net Income Loss
NetIncomeLoss
25565000
CY2017Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-86000
CY2016Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-181000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
CY2017Q2 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
1299000
CY2016Q4 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
3259000
CY2017Q2 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
12245000
CY2016Q4 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
13820000
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2
CY2017Q2 us-gaap Number Of States In Which Entity Operates
NumberOfStatesInWhichEntityOperates
10
CY2017Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
12138000
CY2016Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
14641000
us-gaap Operating Income Loss
OperatingIncomeLoss
28002000
us-gaap Operating Income Loss
OperatingIncomeLoss
32265000
CY2017Q2 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
330650000
CY2017Q2 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
34200000
CY2017Q2 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
34200000
CY2017Q2 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
34200000
CY2017Q2 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
34200000
CY2017Q2 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
34200000
CY2017Q2 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
159650000
CY2017Q2 us-gaap Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
9167000
CY2016Q4 us-gaap Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
9924000
CY2017Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
215986000
CY2016Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
236966000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
18533000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
7472000
CY2017Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
8039000
CY2016Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
10975000
CY2017Q2 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
204000
CY2016Q2 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
261000
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
238000
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
540000
CY2017Q2 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
5054000
CY2016Q2 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
6887000
us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
4646000
us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
11554000
CY2017Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
13297000
CY2016Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
18123000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
12356000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
30627000
CY2017Q2 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
62856000
CY2016Q2 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
57306000
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
126739000
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
118615000
CY2017Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
14623000
CY2016Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
13207000
CY2017Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
17350000
CY2016Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
16302000
CY2017Q2 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
5189000
CY2016Q2 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
4925000
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
9957000
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
9698000
CY2017Q2 us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
11610000
CY2016Q2 us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
11281000
us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
22894000
us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
22763000
us-gaap Other Than Temporary Impairment Losses Investments Availableforsale Securities
OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities
0
CY2016 us-gaap Other Than Temporary Impairment Losses Investments Availableforsale Securities
OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities
0
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
13649000
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
12101000
us-gaap Payments To Acquire Businesses And Interest In Affiliates
PaymentsToAcquireBusinessesAndInterestInAffiliates
176000
us-gaap Payments To Acquire Businesses And Interest In Affiliates
PaymentsToAcquireBusinessesAndInterestInAffiliates
904000
us-gaap Payments To Acquire Notes Receivable
PaymentsToAcquireNotesReceivable
us-gaap Payments To Acquire Notes Receivable
PaymentsToAcquireNotesReceivable
2144000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
16681000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
36127000
us-gaap Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
22775000
us-gaap Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
23852000
CY2017Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3617000
CY2016Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2648000
us-gaap Proceeds From Collection Of Notes Receivable
ProceedsFromCollectionOfNotesReceivable
3651000
us-gaap Proceeds From Collection Of Notes Receivable
ProceedsFromCollectionOfNotesReceivable
428000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1496000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
10070000
us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
970000
us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
44756000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
25697000
us-gaap Proceeds From Sale Of Restricted Investments
ProceedsFromSaleOfRestrictedInvestments
44756000
us-gaap Proceeds From Sale Of Restricted Investments
ProceedsFromSaleOfRestrictedInvestments
25697000
CY2017Q2 us-gaap Profit Loss
ProfitLoss
10569000
CY2016Q2 us-gaap Profit Loss
ProfitLoss
11866000
us-gaap Profit Loss
ProfitLoss
23202000
CY2017Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
949753000
us-gaap Profit Loss
ProfitLoss
25565000
CY2016Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
933140000
CY2017Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
555529000
CY2016Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
559624000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
3795000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
3795000
us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
238000
us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
540000
us-gaap Repayments Of Debt And Capital Lease Obligations
RepaymentsOfDebtAndCapitalLeaseObligations
1715000
us-gaap Repayments Of Debt And Capital Lease Obligations
RepaymentsOfDebtAndCapitalLeaseObligations
1614000
CY2017Q2 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
5748000
CY2016Q2 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
16700000
CY2017Q2 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
3582000
CY2016Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
3125000
CY2017Q2 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
2166000
CY2016Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
2129000
CY2017Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
401192000
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
391934000
us-gaap Revenue Recognition Deferred Revenue
RevenueRecognitionDeferredRevenue
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic;">D</div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic;">eferred Revenue </div></div></div> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic;">&nbsp;</div></div> <div style=" margin: 0pt; text-align: justify; text-indent: 36pt; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">Deferred revenue includes the deferred gain on the sale of assets to National Health Corporation (&#x201c;National&#x201d;), the non-refundable portion</div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;"> (<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10%</div>) of CCRC entrance fees being amortized over the remaining life expectancies of the residents, and premiums received within our workers&#x2019; compensation and professional liability companies that are <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> yet earned. </div></div></div></div></div>
CY2017Q2 us-gaap Self Insurance Reserve
SelfInsuranceReserve
94541000
CY2016Q4 us-gaap Self Insurance Reserve
SelfInsuranceReserve
91162000
CY2017Q2 us-gaap Self Insurance Reserve Current
SelfInsuranceReserveCurrent
25545000
CY2016Q4 us-gaap Self Insurance Reserve Current
SelfInsuranceReserveCurrent
25898000
CY2017Q2 us-gaap Self Insurance Reserve Noncurrent
SelfInsuranceReserveNoncurrent
68996000
CY2016Q4 us-gaap Self Insurance Reserve Noncurrent
SelfInsuranceReserveNoncurrent
65264000
us-gaap Share Based Compensation
ShareBasedCompensation
832000
us-gaap Share Based Compensation
ShareBasedCompensation
494000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.031
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0309
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.166
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.158
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0208
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0089
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
198467
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
61.54
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
656
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
46.69
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
56291
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1124689
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
1854000
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
621390
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
177959
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1270656
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
48.15
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
55.48
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
71.18
CY2016 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
47.16
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
46.54
CY2016 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
62.54
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
72.96
us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
CY2017Q2 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
1270656
us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P4Y292D
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P2Y73D
CY2017Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
1854000
CY2017Q2 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
71.18
us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P4Y146D
CY2016 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
499066
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
31992
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
10070000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1496000
CY2017Q2 us-gaap Stockholders Equity
StockholdersEquity
688669000
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
669611000
CY2015Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
630996000
CY2016Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
671543000
CY2016Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
669611000
CY2017Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
689458000
us-gaap Use Of Estimates
UseOfEstimates
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" margin: 0pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic;">Estimates and Assumptions</div></div> <div style=" margin: 0pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: justify; text-indent: 36pt; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates and could cause our reported net income to vary significantly from period to period.</div></div></div></div></div>
CY2017Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15220448
CY2016Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15289104
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15216336
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15212275
CY2017Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15189818
CY2016Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15266559
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15181700
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15091732

Files In Submission

Name View Source Status
0001437749-17-013682-index-headers.html Edgar Link pending
0001437749-17-013682-index.html Edgar Link pending
0001437749-17-013682.txt Edgar Link pending
0001437749-17-013682-xbrl.zip Edgar Link pending
ex3-5.htm Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32.htm Edgar Link pending
ex4-1.htm Edgar Link pending
ex4-1img001.jpg Edgar Link pending
ex4-1img002.jpg Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
nhc-20170630.xml Edgar Link completed
nhc-20170630.xsd Edgar Link pending
nhc-20170630_cal.xml Edgar Link unprocessable
nhc-20170630_def.xml Edgar Link unprocessable
nhc-20170630_lab.xml Edgar Link unprocessable
nhc-20170630_pre.xml Edgar Link unprocessable
nhc20170630_10q.htm Edgar Link pending
nhc20170630_10qimg002.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending